Sound, UCLA Find Hearing Loss Target

Seattle-based Sound Pharmaceuticals said today that its scientists, along with collaborators at UCLA, have found a new molecular target of interest for the treatment of hearing loss. The target, p27Kip1, was described this week in a presentation at the Association for Research in Otolaryngology. Sound Pharmaceuticals said it is seeking to build on this research by developing a local injection designed to inhibit this target, as a way to restore hearing.

Trending on Xconomy